Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

monday-hello
Today's ASX news
Rask Invest Research Team

ASX 200 Lifts With CSL Shares

The S&P/ASX 200 (INDEXASX: XJO) (^AXJO) and All Ordinaries (INDEXASX: XAO)(^AORD) indices ended slightly higher on Monday as ASX bank shares and CSL Limited (ASX: CSL) lifted the ASX 200.

Today's ASX news
Rask Invest Research Team

S&P/ASX 200 Tipped To Rise

The Australian share market, or S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO), is expected to open higher on Thursday.

smoke-drugs-health-medical-fall-bad
Today's ASX news
Rask Invest Research Team

The S&P/ASX 200 Flopped Today

CSL Limited (ASX:CSL) tried its best to inject some enthusiasm into Australia’s S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) on Wednesday.

ASX shares jump
Today's ASX news
Rask Invest Research Team

S&P/ASX 200 Tipped To Rise

The Australian share market, or S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO), is expected to open higher on Wednesday.

Skip to content